Azithromycin therapy for neutrophilic airways disease: myth or magic? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Editorial

Azithromycin therapy for neutrophilic airways disease: myth or magic?

Free

Authors

Saad F Idris PubMed articles Google scholar articles
Edwin R Chilvers PubMed articles Google scholar articles
Charles Haworth PubMed articles Google scholar articles
Damian McKeon PubMed articles Google scholar articles
Alison M Condliffe PubMed articles Google scholar articles

Dr A M Condliffe, Respiratory Medicine Division, Department of Medicine, University of Cambridge School of Clinical Medicine, Box 157 Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 2QQ, UK; amc46{at}cam.ac.uk

Citation

Idris SF, Chilvers ER, Haworth C, et al

Azithromycin therapy for neutrophilic airways disease: myth or magic?

Thorax 2009;64:186-189.

Publication history

First published February 27, 2009.

Online issue publication

September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group Ltd and the British Thoracic Society